2008

Inspection by sanofi~aventis leads to manufacturing of Endotelon
The GMP inspection by sanofi~aventis held jointly with a representative of Veritas set the beginning of the in-licensed manufacturing of Endotelon.

New products
Tchaikapharma registered the first cancer pharmaceuticals in the company catalog – Bicalodex (bicalutamide) and Irinto (irinotecan hydrochloride trihydrate). The product list was expanded to include Ambrin (ambroxol hydrochloride), Furoser (furosemide), Ketoprofen-Tchaikapharma (ketoprofen), Lisinopril-Tchaikapharma (lisinopril) – now Cordacare. The company received consistent positive feedback from patients and doctors for the high quality, affordability and timely provision of new pharmaceuticals.